Designed and created by Guideline Central in participation with the American College of Chest Physicians
Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents
Patient Guideline Summary
Publication Date: January 1, 2020
Last Updated: March 3, 2023
Objective
Objective
This patient summary means to discuss key recommendations from the American College of Chest Physicians for managing chronic cough due to asthma and NAEB in adults and adolescents. It is limited to adults and adolescents.
Overview
Overview
- Asthma and non-asthmatic eosinophilic bronchitis (NAEB) are among the commonest causes of chronic cough in adults and adolescents.
- Cough can be the only symptom of “cough variant asthma.”
- We will use the abbreviation NAEB throughout this summary to refer to non-asthmatic eosinophilic bronchitis.
- This patient summary focuses on treating cough due to asthma or NAEB.
Diagnosis
Diagnosis
- Because these diagnoses are uncertain, further testing may be required if treatment is unsatisfactory.
- Testing for fractional exhaled nitric oxide (FeNO) or eosinophils (allergy cells) in blood and sputum (phlegm) may be helpful.
Treatment
Treatment
- The first choice for both conditions is inhaled corticosteroids (cortisone) in increasing doses.
- The second choice is an inhaled leukotriene inhibitor.
Abbreviations
- FeNO: Fractional Exhaled Nitric Oxide
- NAEB: Non-asthmatic Eosinophilic Bronchitis
Source Citation
Côté A, Russell RJ, Boulet LP, Gibson PG, Lai K, Irwin RS, Brightling CE; CHEST Expert Cough Panel. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report. Chest. 2020 Jul;158(1):68-96. doi: 10.1016/j.chest.2019.12.021. Epub 2020 Jan 20. PMID: 31972181.
Disclaimer
The information in this patient summary should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.